-
Kyoichi Takahashi
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Yoshitsugu Saishin
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Yumiko Saishin
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Keisuke Mori
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Akira Ando
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Satoru Yamamoto
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Yuji Oshima
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Hiroyuki Nambu
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
Michele B. Melia
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and
-
David P. Bingaman
Alcon Pharmaceutical Products Research, Alcon Research, Ltd., Fort Worth, Texas.
-
Peter A. Campochiaro
From the Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Maryland; and